Govt Issues Alert Against Taking Painkiller Meftal Spas, Says It Can Cause Adverse Reactions

Indian Pharmacopoeia Commission (IPC), Pharma standard body of India, has issued an alert for patients and doctors against a commonly-used painkiller, Meftal.

As per a preliminary analysis conducted by the Pharmacovigilance Programme of India (PvPI), this Drug Rash with Eosinophilia and Systemic symptoms (DRESS) syndrome.

Meftal spas is a readily available painkiller medicine available at any Indian pharmacy. 

The medicine is taken to treat rheumatoid arthritis, osteoarthritis, dysmenorrhea, mild to moderate pain, inflammation, fever and dental pain. 

Because of its easy availability, people pop this pill very often especially when women are on their periods. 

But, in recenbt news, the Indian Pharmacopoeia Commission (IPC) has issued a nation-wide drug safety alert against its use. 

Reports say that, this particular medicine can cause certain adverse effects on people's health which can also impact their internal organs.

The alert that was issued by the government stated that all patients, healthcare professional and consumers are to be very cautious and monitor the possible adverse reactions to the drug in case anyone has consumed it.

The main constituent of this medicine is mefenamic acid and this triggers allergic reactions. 

As per a preliminary analysis conducted by the Pharmacovigilance Programme of India (PvPI), this drug reacts with eosinophilia and systemic symptoms (DRESS) syndrome. 

This syndrome can affect the internal organs of a person.